Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun;14(6):536-42.
doi: 10.1038/ni.2617.

TH2, allergy and group 2 innate lymphoid cells

Paula Licona-Limón  1 , Lark Kyun Kim, Noah W Palm, Richard A Flavell
Affiliations
Review

TH2, allergy and group 2 innate lymphoid cells

Paula Licona-Limón et al. Nat Immunol. 2013 Jun.

Erratum in

  • Nat Immunol. 2014 Jan;15(1):109

Abstract

The initiation of type 2 immune responses by the epithelial cell-derived cytokines IL-25, IL-33 and TSLP has been an area of extensive research in the past decade. Such studies have led to the identification of a new innate lymphoid subset that produces the canonical type 2 cytokines IL-5, IL-9 and IL-13 in response to IL-25 and IL-33. These group 2 or type 2 innate lymphoid cells (ILC2 cells) represent a critical source of type 2 cytokines in vivo and serve an important role in orchestrating the type 2 response to helminths and allergens. Further characterization of ILC2 cell biology will enhance the understanding of type 2 responses and may identify new treatments for asthma, allergies and parasitic infections. Interactions between ILC2 cells and the adaptive immune system, as well as examination of potential roles for ILC2 cells in the maintenance of homeostasis, promise to be particularly fruitful areas of future research.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Exp Med. 2013 Mar 11;210(3):535-49 - PubMed
    1. J Exp Med. 2006 Jun 12;203(6):1435-46 - PubMed
    1. J Exp Med. 2005 Aug 15;202(4):541-9 - PubMed
    1. Nat Rev Immunol. 2011 Jun;11(6):375-88 - PubMed
    1. Annu Rev Immunol. 2010;28:445-89 - PubMed